Clinical Cancer Research, Vol 4, Issue 2 337-342, Copyright © 1998 by American Association for Cancer Research

ARTICLES

Quantitation of DNA from exfoliated colonocytes isolated from human stool surface as a novel noninvasive screening test for colorectal cancer

A Loktionov, IK O'Neill, KR Silvester, JH Cummings, SJ Middleton and R Miller
Dunn Clinical Nutrition Centre, Addenbrooke's Hospital, Cambridge, United Kingdom.

The only widely used screening test for early detection of colorectal cancer, the fecal occult blood test, lacks both sensitivity and specificity because it relies upon incidental bleeding rather than the neoplastic process. With the purpose of developing a new noninvasive diagnostic approach, we quantified DNA extracted from cells isolated from the surface of human stools by a novel procedure. Stools collected from 28 healthy individuals, 17 colorectal cancer patients, and 11 colorectal polyp patients were analyzed. A stool DNA index (SDNAI), expressed as DNA amount in nanograms per gram of stool, had a remarkable 4.5-fold difference in mean values between colorectal cancer patients and healthy people of comparable age. SDNAI was 2133 +/- 407 in the cancer group versus 469 +/- 65 in healthy people of the older (> 50 years) age group (P = 0.0005). The difference was independent of tumor location and size. If 700 ng of DNA/g of stool was taken as a cutoff SDNAI value in discrimination between older healthy people and cancer patients, sensitivity and specificity values reached 1.00 and 0.81, respectively. Age dependence of SDNAI was demonstrated by substantially lower SDNAI values (mean, 227 +/- 41) in younger healthy individuals. Polyp patients sometimes displayed elevated SDNAI values, but considerable variation was observed (mean, 1215 +/- 548). These preliminary findings indicate that SDNAI provides a novel, simple, and powerful noninvasive test for colorectal cancer early detection and screening. The fundamental advantage of the SDNAI is that it directly characterizes colonic epithelium involved in carcinogenesis.

This article has been cited by other articles:

				J. C. Mathers and J. E. Hesketh The Biological Revolution: Understanding the Impact of SNPs on Diet-Cancer Interrelationships J. Nutr., January 1, 2007; 137(1): 253S - 258S. [Abstract] [Full Text] [PDF]

				B. Levin Molecular Screening Testing for Colorectal Cancer Clin. Cancer Res., September 1, 2006; 12(17): 5014 - 5017. [Full Text] [PDF]

				M. H. Lewin, N. Bailey, T. Bandaletova, R. Bowman, A. J. Cross, J. Pollock, D. E.G. Shuker, and S. A. Bingham Red Meat Enhances the Colonic Formation of the DNA Adduct O6-Carboxymethyl Guanine: Implications for Colorectal Cancer Risk Cancer Res., February 1, 2006; 66(3): 1859 - 1865. [Abstract] [Full Text] [PDF]

				A. M. JUBB, P. QUIRKE, and A. J. OATES DNA Methylation, a Biomarker for Colorectal Cancer: Implications for Screening and Pathological Utility Ann. N.Y. Acad. Sci., March 1, 2003; 983(1): 251 - 267. [Abstract] [Full Text] [PDF]

				W. Atkin and J. P. Martin Stool DNA-Based Colorectal Cancer Detection: Finding the Needle in the Haystack J Natl Cancer Inst, June 6, 2001; 93(11): 798 - 799. [Full Text] [PDF]

				D. A Ahlquist Molecular stool screening for colorectal cancer BMJ, July 29, 2000; 321(7256): 254 - 255. [Full Text]